Bristol-Myers Squibb Wins FDA Approval for Opdivo-Yervoy Combo in First-Line HCC Treatment
Bristol-Myers Squibb (BMS, NYSE: BMY) has secured another indication approval from the US Food and...
Company
Jiangxi Institute of Biological Products Files for Hong Kong IPO Amid Strong Market Position
Jiangxi Institute of Biological Products Inc., China’s largest provider and exporter of human tetanus antitoxin...
Zhaoke Ophthalmology Launches Phase II Study for Brimochol PF in Presbyopia Treatment
Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the initiation of a multi-center, double-blinded, crossover, placebo-controlled...
CSPC Pharmaceutical Gains NMPA Approval for Clinical Trial of SYH2046 in Heart Failure
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) has announced that it has received approval from...
Amgen’s Imdelltra Shows Positive Phase III Results in Small Cell Lung Cancer
US biotech giant Amgen (NASDAQ: AMGN) has announced positive results from the global Phase III...
Shanghai Microport EP Medtech Secures NMPA Fast-Track Designation for EasyEcho Catheter
China’s Shanghai Microport EP Medtech Co., Ltd (SHA: 688351) has announced that it has received...
Jiangsu Hengrui Secures NMPA Approval for Clinical Trials of SHR-3792 and HRS-9190
China-based Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) has announced that it has received separate...
Johnson & Johnson Launches Rybrevant in China for EGFR Exon 20 Insertion Mutation Lung Cancer
US pharmaceutical giant Johnson & Johnson (J&J, NYSE: JNJ) has officially launched Rybrevant (amivantamab), an...
Tasly Pharma Gains NMPA Green Light for CAR-T Therapy Clinical Study in Recurrent Glioblastoma
China-based Tasly Pharma Co., Ltd (SHA: 600535) has announced that it has received approval from...
CR Boya Gains NMPA Approval for Clinical Trials of Subcutaneous Human Immunoglobulin
China-based CR Boya Biological Pharmacy Co. Ltd. (SHE: 300294) has announced that it has received...
Novartis Announces USD 23 Billion Investment to Expand U.S. Manufacturing and R&D Hubs
Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced plans to invest USD 23 billion over...
Juventas Cell Therapy Secures China Clinical Trial Approval for Inaticabtagene Autoleucel in AIHA
Chinese firm Juventas Cell Therapy Ltd has obtained tacit clinical trial approval in China for...
Belief BioMed and Takeda Win NMPA Approval for China’s First Hemophilia B Gene Therapy
China-based gene therapy specialist Belief BioMed Inc. and Takeda’s (NYSE: TAK, TYO: 4502) China unit...
Zai Lab’s Partner argenx Secures FDA Approval for Vygart Hytrulo Prefilled Syringe in gMG and CIDP
China-based Zai Lab Limited (NASDAQ: ZLAB, HKG: 9688) and its Dutch partner argenx SE (NASDAQ:...
Pierre Fabre and RedRidge Bio Partner on Biparatopic Antibody Development for Precision Oncology
France’s Pierre Fabre Laboratories has entered into a strategic partnership with Switzerland-based RedRidge Bio AG...
INTCO Medical and JD Healthcare Partner to Innovate ‘Internet + Healthcare’ Service Models
China-based INTCO Medical (SHE: 300677), a high-tech manufacturer of medical consumables and equipment, has entered...
KingstronBio’s Prostyle A Valve Gains NMPA Approval, Setting New Benchmark in Transcatheter Aortic Valve Replacement
KingstronBio, a Changshu-based structural heart disease device manufacturer, has obtained marketing approval from China’s National...
iRegene Therapeutics Secures RMB 100 Million in Series B+ Financing to Advance iPSC Technology
Wuhan-based iRegene Therapeutics, a pioneer in AI-powered, chemically induced cell therapies, has reportedly raised close...
Novo Nordisk Invests BRL 6.4 Billion in Brazilian Manufacturing Expansion for Obesity Drugs
Denmark-based Novo Nordisk A/S (NYSE: NVO) has announced a significant investment of BRL 6.4 billion...
Jemincare Group Announces NMPA Approval of Generic Clenil for Asthma Treatment
China-based Jiangxi Jemincare Group has announced that it has received marketing approval from the National...